Company Name: Coherus BioSciences, Inc.
Coherus BioSciences, Inc. is engaged in the development and commercialization of biosimilar therapeutics. The company’s therapeutic franchises include:
- Oncology biosimilar candidates
- Immunology (anti-TNF) biosimilar candidates
- Ophthalmology biosimilar candidate
- Multiple sclerosis (MS) small molecule therapeutic candidate
Ticker Symbol: CHRS (NASDAQ)
Company Website: www.coherus.com
Social Media: Coherus BioSciences LinkedIn
Headquarters: Redwood City, California